Skip to content
⌘KStart free
AI InfrastructureDefenseQuantumAll studies →

Zivo Bioscience, Inc. ZIVO US Equity

OTC+ CompareTear sheet →
Health Care · CIK 1101026 · FY ends Dec 31
$4.27
+0.00 (+0.00%)
USD · as of 2026-08-28 · marketstack

Zivo Bioscience, Inc. (OTC: ZIVO), an SEC filer in Biological Products, (No Diagnostic Substances), closed at $4.27, +0.0%, on 2026-08-28, with a market cap of $17M as of 2026-08-26 and a net margin of -8513.4%. Institutional ownership, earnings history and filed financials are on the tabs below.

Short interest· FINRA consolidated · settlement 2026-08-14

6 settlement cycles
Shares short8K
% of shares out0.2%
Days to cover45.1
Δ vs 2026-07-31-2.0%
▲ 8K shares shortline top = 45.1d to cover2026-05-29: 8K short · 10.4d to cover2026-052026-06-15: 8K short · 6.5d to cover2026-062026-06-30: 8K short · 2.7d to cover2026-062026-07-15: 8K short · 5.7d to cover2026-072026-07-31: 8K short · 4.8d to cover2026-072026-08-14: 8K short · 45.1d to cover2026-08

bars = shares short · line = days to cover (own scale)

SettlementShares shortΔ vs priorAvg daily volumeDays to cover
2026-08-148,164-2.0%18145.1
2026-07-318,329+6.6%1,7454.8
2026-07-157,811-2.7%1,3605.7
2026-06-308,031-0.5%3,0142.7
2026-06-158,071-3.9%1,2406.5
2026-05-298,397-5.3%80910.4

FINRA Rule 4560 · twice monthly, published ~a week later.

most-shorted stocks →data sources →institutional holders (OWN) →

Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.

Related →Most-shorted stocks (SI)Ownership (OWN)Data sources